Gf Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-07-2024
- Paid Up Capital ₹ 0.10 M
as on 10-07-2024
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 M
as on 10-07-2024
- Revenue -48.22%
(FY 2020)
- Profit 560.06%
(FY 2020)
- Ebitda -150.53%
(FY 2020)
- Net Worth 3.08%
(FY 2020)
- Total Assets 6.05%
(FY 2020)
About Gf Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Sachin Mahajan, Ashish Dehankar, Parag Rajnikant, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2006PTC161580
- Company No.
161580
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationM G Road,Akola-444001, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gf Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Mahajan  | Managing Director | 03-May-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Dehankar | Director | 03-May-2006 | Current |
| Parag Rajnikant | Director | 03-May-2006 | Current |
| Mohd Akbani | Director | 03-May-2006 | Current |
Financial Performance of Gf Biotech.
Gf Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 48.22% decrease. The company also saw a substantial improvement in profitability, with a 560.06% increase in profit. The company's net worth moved up by a moderate rise of 3.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gf Biotech?
In 2018, Gf Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Akola Surgicals Private LimitedActive 19 years 9 monthsSachin Mahajan, Ashish Dehankar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Yavatmal Urban Co- Operative Bank Ltd Creation Date: 07 Mar 2013 | ₹1.50 M | Open |
How Many Employees Work at Gf Biotech?
Unlock and access historical data on people associated with Gf Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gf Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gf Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
